07-09-2018 | Insulin | News
The results of a network meta-analysis suggest that long-acting insulin analogs have broadly equivalent efficacy and safety in patients with type 2 diabetes, although some might be a little better for preventing nocturnal hypoglycemia.
08-23-2017 | Obesity | Review | Article
Mottalib A et al. Curr Diab Rep 2017; 17: 92. doi: 10.1007/s11892-017-0918-8
08-18-2017 | Insulin | Review | Article
Frias PF, Frias JP. Curr Diab Rep 2017; 17: 91. doi: 10.1007/s11892-017-0926-8